FDA Renews EUA for Convalescent Plasma & Issues Cease & Desist for Unapproved Drugs & Covid Tests ...Middle East

Thepintree.net - News
FDA Renews EUA for Convalescent Plasma & Issues Cease & Desist for Unapproved Drugs & Covid Tests
Washington, DC…The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA has reissued the August 23, 2020 emergency use authorization (EUA) for the emergency use of COVID-19 convalescent plasma for the treatment of hospitalized patients with COVID-19. The Letter of Authorization has been revised to add the Mount Sinai COVID-19 ELISA IgG Antibody Test as an acceptable test to be used for the purpose of qualifying high and low titer COVID-19 convalescent plasma in the manufacture of COVID-19 convalescent plasma. As part of the FDA’s effort to protect consumers, the agency issued a warning letter jointly

Hence then, the article about fda renews eua for convalescent plasma issues cease desist for unapproved drugs covid tests was published today ( ) and is available on Thepintree.net ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Renews EUA for Convalescent Plasma & Issues Cease & Desist for Unapproved Drugs & Covid Tests )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News